These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 11041183)
41. Three years' experience with the sorin pericarbon stentless prosthesis: mid-term results with three different implantation techniques. Nagy ZL; Bodi A; Len A; Balogh I; Peterffy A J Heart Valve Dis; 2005 Jan; 14(1):72-7. PubMed ID: 15700439 [TBL] [Abstract][Full Text] [Related]
42. The outcomes of operations for 539 patients with Ebstein anomaly. Brown ML; Dearani JA; Danielson GK; Cetta F; Connolly HM; Warnes CA; Li Z; Hodge DO; Driscoll DJ; J Thorac Cardiovasc Surg; 2008 May; 135(5):1120-36, 1136.e1-7. PubMed ID: 18455593 [TBL] [Abstract][Full Text] [Related]
44. The aortic Elan stentless aortic valve: excellent hemodynamics and ease of implantation. Flynn M; Iaccovoni A; Pathi V; Butler J; Macarthur KJ; Berg GA Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):48-54. PubMed ID: 11805949 [TBL] [Abstract][Full Text] [Related]
45. [A case of Ebstein disease and its surgical repair with dura-mater prosthesis]. Macedo MM; Antunes AM; Fragoso JB; de Bettencourt JM Rev Port Cardiol; 2001 May; 20 Suppl 5():V-37-42; discussion V-43-5. PubMed ID: 11515299 [TBL] [Abstract][Full Text] [Related]
46. Electrocardiographic characteristics of patients with Ebstein's anomaly before and after ablation of an accessory atrioventricular pathway. Iturralde P; Nava S; Sálica G; Medeiros A; Márquez MF; Colin L; Victoria D; De Micheli A; Gonzalez MD J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1332-6. PubMed ID: 17239096 [TBL] [Abstract][Full Text] [Related]
47. Aortic valve-in-valve implantation: impact of transcatheter- bioprosthesis size mismatch. Azadani AN; Jaussaud N; Matthews PB; Chuter TA; Ge L; Guy TS; Guccione J; Tseng EE J Heart Valve Dis; 2009 Jul; 18(4):367-73. PubMed ID: 19852139 [TBL] [Abstract][Full Text] [Related]
48. Early and midterm results in anatomic repair of Ebstein anomaly. Wu Q; Huang Z; Pan G; Wang L; Li L; Xue H J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1438-40; discussion 1440-2. PubMed ID: 18023660 [TBL] [Abstract][Full Text] [Related]
49. The Stentless Cryo-Life O'Brien porcine aortic valve at 10 years. Hvass U; Baron F; Elsebaey A; Nguyen D; Flecher E J Heart Valve Dis; 2004 Nov; 13(6):977-83; discussion 983. PubMed ID: 15597593 [TBL] [Abstract][Full Text] [Related]
50. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis. Mykén PS J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875 [TBL] [Abstract][Full Text] [Related]
51. Functional status after operation for Ebstein anomaly: the Mayo Clinic experience. Brown ML; Dearani JA; Danielson GK; Cetta F; Connolly HM; Warnes CA; Li Z; Hodge DO; Driscoll DJ J Am Coll Cardiol; 2008 Aug; 52(6):460-6. PubMed ID: 18672167 [TBL] [Abstract][Full Text] [Related]
52. Short-term hemodynamic performance of the Sorin Freedom SOLO stentless valve. Da Col U; Di Bella I; Bardelli G; Ramoni E; Affronti A; Vidili A; Ragni T J Heart Valve Dis; 2007 Sep; 16(5):546-50. PubMed ID: 17944127 [TBL] [Abstract][Full Text] [Related]
53. [Case of successful replacement of an earlier implanted xenoaortic prosthesis in Ebstein's anomaly]. Podzolkov VP; Makhmudov MM; Stranin VG; Iaroshinskiĭ IuN; Mitina IN Grudn Khir; 1984; (5):84-6. PubMed ID: 6500355 [No Abstract] [Full Text] [Related]